Krabbe disease: an overview.

Area of Science:

• Neuroscience
• Genetics
• Biochemistry

Background:

• Krabbe disease, also known as globoid cell leukodystrophy, is a severe neurodegenerative disorder.
• It stems from a deficiency in the lysosomal enzyme galactosylceramidase.
• This deficiency leads to the accumulation of galactocerebroside, damaging myelin and causing progressive white matter disease.

Purpose of the Study:

• To review the clinical manifestations of Krabbe disease.
• To discuss diagnostic and staging methods.
• To summarize current understanding of disease mechanisms and outline therapeutic options.

Main Methods:

• Literature review of Krabbe disease mechanisms, diagnosis, and treatment.
• Analysis of factors influencing disease severity, including mutations and enzyme activity.

Main Results:

• Disease severity correlates with causal mutations and residual enzyme activity.
• Accumulation of galactocerebroside is the key pathological process.
• A range of diagnostic and therapeutic strategies are available or under investigation.

Conclusions:

• Understanding disease mechanisms is crucial for developing effective treatments.
• Early diagnosis and appropriate staging are vital for patient management.
• Therapeutic approaches range from current standards to investigational therapies for globoid cell leukodystrophy.